Abstract: Disclosed herein are ink compositions including an ink vehicle and a colorant, wherein the ink vehicle includes a compound having a formula of R1—CONH—R2 or R2—CONH—R1, wherein R2 is a methyl group and R1 is an alkyl group having from about 3 carbon atoms to about 200 carbon atoms.

Abstract: Disclosed herein are ink compositions including an ink vehicle and a colorant, wherein the ink vehicle includes a compound having a formula of R1—CONH—R2 or R2—CONH—R1, wherein R2 is an alkyl group having from 1 to about 18 carbon atoms and R1 is an alkyl group having from about 3 carbon atoms to about 200 carbon atoms, wherein R2 and R1 have the same number of carbon atoms or R2 has less carbon atoms than R1, and wherein at least one of the alkyl groups for R2 and R1 includes at least one hydroxyl group substituent.

Abstract: A polymer that is a polysiloxane polymer has fluoroquinolone antibiotic groups, or pharmaceutically acceptable salts thereof, attached via linkers. The linkers may be hydrolytically labile thereby providing a manner of releasing the fluoroquinolone antibiotic from the polymer.

Abstract: An ink composition that includes stearyl stearamide, N,N?-ethylene bisoleamide, at least one wax, at least one antioxidant, and at least one solvent dye colorant is useful as a phase change ink.

Abstract: A polymer that is a polysiloxane polymer has fluoroquinolone antibiotic groups, or pharmaceutically acceptable salts thereof, attached via linkers. The linkers may be hydrolytically labile thereby providing a manner of releasing the fluoroquinolone antibiotic from the polymer.

Abstract: Disclosed herein are ink compositions including an ink vehicle and a colorant, wherein the ink vehicle comprises a compound having a formula of: R1—CONH—R6—CONH—R3, R1—NHCO—R6—CONH—R3, R1—CONH—R6—NHCO—R3, R1—NHCO—R6—NHCO—R3, R1—CONH—R6—CONH—C34H64+n—CONH—R6—CONH—R3, R1—NHCO—R6—NHCO—C34H64+n—NHCO—R6—NHCO—R3, R1—CONH—R6—NHCO—C34H64+n—CONH—R6—NHCO—R3, R1—NHCO—R6—CONH—C34H64+n—NHCO—R6—CONH—R3, R1—CONH—R4—CONH—C34H64+n—CONH—R5—CONH—R3, R1—CONH—R4—NHCO—C34H64+n—CONH—R5—NHCO—R3, R1—NHCO—R4—CONH—C34H64+n—NHCO—R5—CONH—R3, R1—NHCO—R4—NHCO—C34H64+n—CONH—R5—CONH—R3, or R1—CONH—R4—CONH—C34H64+n—NHCO—R5—NHCO—R3, wherein n is an integer of 0, 1, 2, 3, 4, 5 or 6, R6 is a cyclic group having from 5 to 8 carbon atoms, R1 and R3 each comprise a branched alkyl group derived from isostearic acid, and R4 and R5 are the same or different and comprise an alkylene having from 1 to about 200 carbon atoms or

Abstract: A polymer that is a polysiloxane polymer has Levofloxacin groups, or pharmaceutically acceptable salts thereof, attached via linkers. The linkers may be hydrolytically labile thereby providing a manner of releasing the Levofloxacin from the polymer.

Abstract: Disclosed herein are compounds having a formula of R1—CONH—R6—CONH—R3, R1—NHCO—R6—CONH—R3, R1—CONH—R6—NHCO—R3 or R1—NHCO—R6—NHCO—R3, wherein R6 is a cyclic group having from 5 to 8 carbon atoms, wherein R1 and R3 are the same or different and comprise an alkyl group having from about 3 carbon atoms to about 200 carbon atoms, and wherein one or both of R1 and R3 include at least one hydroxyl group substituent, and ink compositions including the compounds as an ink vehicle.

Abstract: Disclosed herein are compounds having a formula of: R1—CONH—R6—CONH—C34H64+n—CONH—R6—CONH—R3, R1—NHCO—R6—NHCO—C34H64+n—NHCO—R6—NHCO—R3, R1—CONH—R6—NHCO—C34H64+n—CONH—R6—NHCO—R3, R1—NHCO—R6—CONH—C34H64+n—NHCO—R6—CONH—R3, R1—CONH—R4—CONH—C34H64+n—CONH—R5—CONH—R3, R1—CONH—R4—NHCO—C34H64+n—CONH—R5—NHCO—R3, R1—NHCO—R4—CONH—C34H64+n—NHCO—R5—CONH—R3, R1—NHCO—R4—NHCO—C34H64+n—CONH—R5—CONH—R3, or R1—CONH—R4—CONH—C34H64+n—NHCO—R5—NHCO—R3, wherein n is an integer of 0, 2 or 4, R6 is the same or different cyclic group having from 5 to 8 carbon atoms, R4 and R5 are the same or different and comprise an alkylene having from 1 to about 200 carbon atoms, and R1 and R3 are the same or different and comprise a straight chain or branched alkyl group having from about 3 carbon atoms to about 200 carbon atoms and one or both of R1 and R3 include at least one hydroxyl group substituent, and ink compositions including the compounds as an ink vehicle.

Abstract: Disclosed herein are ink compositions including an ink vehicle and a colorant, wherein the ink vehicle includes a compound having a formula of R1—CONH—R2 or R2—CONH—R1, wherein R2 is an alkyl group having from 1 to about 18 carbon atoms and R1 is an alkyl group having from about 3 carbon atoms to about 200 carbon atoms, wherein R2 and R1 have the same number of carbon atoms or R2 has less carbon atoms than R1, and wherein at least one of the alkyl groups for R2 and R1 includes at least one hydroxyl group substituent.

Abstract: Disclosed herein are ink compositions including an ink vehicle and a colorant, wherein the ink vehicle includes a compound having a formula of R1—CONH—R2 or R2—CONH—R1, wherein R2 is a methyl group and R1 is an alkyl group having from about 3 carbon atoms to about 200 carbon atoms.

Abstract: Disclosed herein are ink compositions including an ink vehicle and a colorant, wherein the ink vehicle comprises a compound having a formula of: R1—CONH—R6—CONH—R3, R1—NHCO—R6—CONH—R3, R1—CONH—R6—NHCO—R3, R1—NHCO—R6—NHCO—R3, R1—CONH—R6—CONH—C36H64+n—CONH—R6—CONH—R3, R1—NHCO—R6—NHCO—C36H64+n—NHCO—R6—NHCO—R3, R1—CONH—R6—NHCO—C36H64+n—CONH—R6—NHCO—R3, R1—NHCO—R6—CONH—C36H64+n—NHCO—R6—CONH—R3, R1—CONH—R4—CONH—C36H64+n—CONH—R5—CONH—R3, R1—CONH—R4—NHCO—C36H64+n—CONH—R5—NHCO—R3, R1—NHCO—R4—CONH—C36H64+n—NHCO—R5—CONH—R3, R1—NHCO—R4—NHCO—C36H64+n—CONH—R5—CONH—R3, or R1—CONH—R4—CONH—C36H64+n—NHCO—R5—NHCO—R3, wherein n is an integer of 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10, R6 is a cyclic group having from 5 to 8 carbon atoms, R1 and R3 each comprise a branched alkyl group derived from isostearic acid, and R4 and R5 are the same or different and comprise an alkylene having from 1 to about 200 carbon atoms or

Abstract: Disclosed herein are compounds having a formula of R1—CONH—R6—CONH—R3, R1—NHCO—R6—CONH—R3, R1—CONH—R6—NHCO—R3 or R1—NHCO—R6—NHCO—R3, wherein R6 is a cyclic group having from 5 to 8 carbon atoms, wherein R1 and R3 are the same or different and comprise an alkyl group having from about 3 carbon atoms to about 200 carbon atoms, and wherein one or both of R1 and R3 include at least one hydroxyl group substituent, and ink compositions including the compounds as an ink vehicle.

Abstract: Disclosed herein are compounds having a formula of: R1—CONH—R6—CONH—C36H64+n—CONH—R6—CONH—R3, R1—NHCO—R6—NHCO—C36H64+n—NHCO—R6—NHCO—R3, R1—CONH—R6—NHCO—C36H64+n—CONH—R6—NHCO—R3, R1—NHCO—R6—CONH—C36H64+n—NHCO—R6—CONH—R3, R1—CONH—R4—CONH—C36H64+n—CONH—R5—CONH—R3, R1—CONH—R4—NHCO—C36H64+n—CONH—R5—NHCO—R3, R1—NHCO—R4—CONH—C36H64+n—NHCO—R5—CONH—R3, R1—NHCO—R4—NHCO—C36H64+n—CONH—R5—CONH—R3, or R1—CONH—R4—CONH—C36H64+n—NHCO—R5—NHCO—R3, wherein n is an integer of 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10, R6 is the same or different cyclic group having from 5 to 8 carbon atoms, R4 and R5 are the same or different and comprise an alkylene having from 1 to about 200 carbon atoms, and R1 and R3 are the same or different and comprise a straight chain or branched alkyl group having from about 3 carbon atoms to about 200 carbon atoms and one or both of R1 and R3 include at least one hydroxyl group substituent, and ink compositions including the compounds as an ink vehicle.

Abstract: Disclosed herein are amide compounds suitable for use in ink compositions, and methods of making the amide compounds disclosed herein.

Abstract: A polymer that is a polysiloxane polymer has Levofloxacin groups, or pharmaceutically acceptable salts thereof, attached via linkers. The linkers may be hydrolytically labile thereby providing a manner of releasing the Levofloxacin from the polymer.